Yayınlar & Eserler

Yayın Ağı
Makaleler 64
Tümü (64)
SCI-E, SSCI, AHCI (53)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (2)
Scopus (56)
TRDizin (9)
Diğer Yayınlar (6)

1. Genomic diagnosis and multisystem phenotyping in pediatric congenital analbuminemia: clinical, coagulation, and immune signatures

Sefer A. P., Yorgun Altunbas M., ERMAN B., Can S., Bulutoglu A., Hubrack S., et al.
Frontiers in Pediatrics , cilt.14, ss.1-15, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Pilot study: the impact of simulation-based pediatric basic life support training on the performance of caregivers of children with Rett syndrome.

Kocyigit S., Akgun-Dogan Ö., Hatırnaz Ng Ö., Alanay Y., Guven F.
BMC medical education , 2026 (SCI-Expanded, SSCI, Scopus)

3. Genomic Dissection of Pediatric Protein-Losing Enteropathy and Related Disorders: Clinical, Immunologic, and Therapeutic Insights

Sefer A. P., ERMAN B., BARIŞ S., Karakoc-Aydiner E., Aydogdu E. S., Cevahir S., et al.
Gastroenterology , cilt.170, sa.4, ss.821-825, 2026 (SCI-Expanded, Scopus)

4. Periodic Genetic Reanalysis Identifies a Novel De Novo NOTCH1 Variant: A Case Report

AYDIN E., BULUT A. Ş., Yildiz B., Ozonur U., ÖZDEMİR Ö., BİLGÜVAR K., et al.
JOURNAL OF CHILD NEUROLOGY , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. DNA Methylation Signatures Distinguish Breast Cancer Histological Subtypes and Predict Hormone Receptor Status: A TCGA-Based Integrative Analysis

ÖZDEMİR Ö., AYDIN E., DEMİRCİ T., Telciyan K., AKKUŞ A., YÜCESAN E., et al.
Experimed , cilt.16, sa.2, ss.157-176, 2026 (ESCI, Scopus, TRDizin)

6. Expanding the Phenotypic Spectrum of ERLIN1-Related SPG62: Report of Two Siblings With Behavioral Features and Hyperacusis

Ozkose G. S., Topçu Y., Ay B., Özdemir Ö., Akgün Doğan Ö., Hatirnaz Ng Ö., et al.
Clinical Genetics , cilt.109, sa.1, ss.149-154, 2026 (SCI-Expanded, Scopus)

7. Identification of nonsense variants in the ATM gene mimicking SCID phenotype: a brief report

Firtina S., Saritas M., Ng Y. Y., Nepesov S., Kiykim A., Bozkurt S., et al.
Immunologic Research , cilt.73, sa.1, 2025 (SCI-Expanded, Scopus)

8. Clinical management of three JMML siblings with germline CBL variation

Agaoglu N. B., Yalcın K., Unal B., Onder G., Celen S. S., Zhumatayev S., et al.
Cancer Genetics , cilt.292-293, ss.120-123, 2025 (SCI-Expanded, Scopus)

9. Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer

Agaoglu N. B., HATIRNAZ NG Ö., Zemheri I. E., Unal B., Gerenli N., Tosun I., et al.
American Journal of Medical Genetics, Part A , cilt.197, sa.2, 2025 (SCI-Expanded, Scopus)

10. Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients.

Erbilgin Y., Firtina S., Kirat E., Khodzhaev K., Karakas Z., Ünüvar A., et al.
Biochemical genetics , 2025 (SCI-Expanded, Scopus)

11. Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition

ÖNDER G., ÖZDEMİR Ö., Taylan F., CANPOLAT C., Yalcin K., Erbey F., et al.
Frontiers in Genetics , cilt.16, 2025 (SCI-Expanded, Scopus)

12. Statistical analysis of genomic in-silico pathogenicity predictors for the characterization of VUS in rare and undiagnosed disorders

AYDIN E., Ergun B., AKGÜN DOĞAN Ö., ALANAY Y., HATIRNAZ NG Ö., ÖZDEMİR Ö.
EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.32, ss.1172, 2024 (SCI-Expanded, Scopus)

13. Statistical analysis of genomic in-silico pathogenicity predictors for the characterization of VUS in rare and undiagnosed disorders

AYDIN E., Ergun B., AKGÜN DOĞAN Ö., ALANAY Y., HATIRNAZ NG Ö., ÖZDEMİR Ö.
EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1172, 2024 (SCI-Expanded, Scopus)

14. Long-term immunological changes after corrective cardiac surgery

BİLGİÇ ELTAN S., Amirov R., Babayeva R., Altunbas M. Y., Karakurt T., CAN S., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , cilt.100, sa.6, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon

Delgado-Vega A. M., Cederroth H., Taylan F., Ekholm K., Ek M., Thonberg H., et al.
NATURE GENETICS , cilt.56, sa.11, ss.2287-2294, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Turkiye

ÖZDEMİR Ö., Bychkovsky B. L., Unal B., ÖNDER G., Amanvermez U., AYDIN E., et al.
CANCERS , cilt.16, sa.22, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Rapid genome sequencing for critically ill infants: an inaugural pilot study from Turkey

Guner Yilmaz B., Akgun-Dogan Ö., Ozdemir Ö., Yuksel B., Hatirnaz Ng Ö., Bilguvar K., et al.
FRONTIERS IN PEDIATRICS , cilt.12, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Genomic disparity impacts variant classification of cancer susceptibility genes in Turkish breast cancer patients

Agaoglu N. B., Unal B., Hayes C. P., Walker M., HATIRNAZ NG Ö., Doganay L., et al.
CANCER MEDICINE , cilt.13, sa.3, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Memantine and SKF82958 but not an enriched environment modulate naloxone-precipitated morphine abstinence syndrome without affecting hippocampal tPA mRNA levels in rats

Aslan A., Hatirnaz-Ng Ö., Tasar O., Ozbek U., Yamanturk-Celik P.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.234, 2024 (SCI-Expanded, Scopus)

20. A new line method; A direct test in spinal muscular atrophy screening for DBS

Kubar A., Temel S. G., Beken S., Onder G., Hatirnaz Ö., Korkmaz A., et al.
Molecular Genetics and Genomic Medicine , cilt.11, sa.12, 2023 (SCI-Expanded, Scopus)

21. TNFRSF13B VARYANTLARI, YAYGIN DEĞİŞKEN İMMÜN YETMEZLİK KLİNİK FENOTİPİNİN DÜZENLENMESİNDE ROL OYNAR

Firtina S., YENENLER-KUTLU A., Işıkgil B., Yozlu M., CEPECI B. N., Yilmaz H., et al.
Sabiad , cilt.6, sa.3, ss.210-218, 2023 (TRDizin)

22. Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey

Lazic J., Haas O. A., Özbek U., Ripperger T., Byrjalsen A., Te Kronnie G., et al.
Pediatric Blood and Cancer , cilt.70, sa.5, 2023 (SCI-Expanded, Scopus)

23. Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.

Firtina S., Erbilgin Y., Hatirnaz Ng Ö., Karaman S., Karakas Z., Celkan T. T., et al.
Scandinavian journal of clinical and laboratory investigation , cilt.83, sa.3, ss.187-193, 2023 (SCI-Expanded, Scopus)

24. Functional characterization of genomic variants of uncertain significance (VUS) in the ATM gene

Yilmaz S. U., Manto K., Ozdemir O., Agaoglu N. B., HATIRNAZ NG Ö., MÜFTÜOĞLU M., et al.
BREAST , cilt.68, 2023 (SCI-Expanded, Scopus)

25. Obstacles and expectations of rare disease patients and their families in Turkiye: ISTisNA project survey results

Hatirnaz Ng Ö., Sahin I., Erbilgin Y., Ozdemir Ö., Yucesan E., Erturk N., et al.
FRONTIERS IN PUBLIC HEALTH , cilt.10, 2023 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma

26. Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family

Agaoglu N. B., HATIRNAZ NG Ö., Unal B., AKGÜN DOĞAN Ö., Amanvermez U., Yildiz J., et al.
CANCER GENETICS , cilt.268-269, ss.128-136, 2022 (SCI-Expanded, Scopus)

27. Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.

Hatırnaz Ng Ö., Eşkazan A. E.
Translational oncology , cilt.19, ss.101394, 2022 (SCI-Expanded, Scopus)

28. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls

Senturk G., Ng Y. Y., Eltan S. B., Baser D., Ogulur I., Altindirek D., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY , cilt.95, sa.3, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Primary antibody deficiencies in Turkey: molecular and clinical aspects

Firtina S., Ng Y. Y., HATIRNAZ NG Ö., Kiykim A., Ozek E. Y., Kara M., et al.
IMMUNOLOGIC RESEARCH , cilt.70, sa.1, ss.44-55, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia

Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., KARAKAŞ Z., Kucukcankurt F., et al.
LEUKEMIA & LYMPHOMA , cilt.63, sa.12, ss.2931-2939, 2022 (SCI-Expanded, Scopus)

31. Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure.

Hatirnaz N., Akyoney S., Sahin I., Soykam H., Bayram A., Ozdemir Ö., et al.
PloS one , cilt.16, sa.12, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

32. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.

ERBİLGİN Y., Ng Ö., Can I., Firtina S., Kucukcankurt F., KARAMAN S., et al.
International journal of laboratory hematology , cilt.43, sa.5, ss.1093-1103, 2021 (SCI-Expanded, Scopus)

33. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.

Turan R. D., Tastan C., Kancagi D. D., Yurtsever B., Karakus G. S., Ozer S., et al.
Scientific reports , cilt.11, sa.1, ss.15799, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates

Sir Karakus G., Tastan C., Dilek Kancagi D., Yurtsever B., Tumentemur G., Demir S., et al.
SCIENTIFIC REPORTS , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

35. Mutational landscape of severe combined immunodeficiency patients from Turkey

Çekiç Ş., Ng Y. Y., Ng Ö., Kıykım A., Özen A. O., Özen A. O., et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS , cilt.47, sa.6, ss.529-538, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Copy-number variations in adult patients with chronic immune thrombocytopenia.

YÜCESAN E., Ng Ö., Yalniz F. F., Yilmaz H., SALİHOĞLU A., Sudutan T., et al.
Expert review of hematology , cilt.13, sa.11, ss.1277-1287, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. The potential protective roles of zinc, selenium and glutathione on hypoxia-induced TRPM2 channel activation in transfected HEK293 cells

Ergun D. D., Dursun S., PASTACI ÖZSOBACI N., HATIRNAZ NG Ö., NAZIROĞLU M., ÖZÇELİK D.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , cilt.40, sa.6, ss.521-530, 2020 (SCI-Expanded, Scopus)

38. High TUBB2A expression in childhood T-ALL is correlated with the clinical outcome

Khodzhaev K., HATIRNAZ NG Ö., TUĞCU D., ERBİLGİN Y., Ng Y. Y., Celkan T., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , cilt.42, sa.5, ss.581-588, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Hydrogen Sulphide and Nitric Oxide Cooperate in Cardioprotection Against Ischemia/Reperfusion Injury in Isolated Rat Heart.

ÜSTÜNOVA S., TAKIR S., YILMAZER N., Bulut H., ALTINDİREK D., HATIRNAZ NG Ö., et al.
In vivo (Athens, Greece) , cilt.34, sa.5, ss.2507-2516, 2020 (SCI-Expanded, Scopus) Creative Commons License

40. Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect

Khodzhaev K., Bay S. B., Kebudi R., ALTINDİREK D., Kaya A., Erbilgin Y., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , cilt.40, sa.6, ss.883-892, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia

Kucukcankurt F., Erbilgin Y., Firtina S., Hatirnaz Ö., Karakas Z., Celkan T., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.98-103, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

42. Tanısı Zor Tek Gen Hastalıklarında Hedefe Yönelik Yeni Nesil Dizileme Panel Tasarımı: Primer İmmün Yetersizlik Örneği

FIRTINA S., NG Y. Y., HATIRNAZ NG Ö., SAYİTOĞLU M.
Sabiad , cilt.3, 2020 (TRDizin)

43. Prognostic gene alterations and clonal changes in childhood B-ALL.

ERBİLGİN Y., Firtina S., Mercan S., Ng Ö., KARAMAN S., Tasar O., et al.
Leukemia research , cilt.83, ss.106159, 2019 (SCI-Expanded, Scopus)

44. A Novel FOXN1 Variant Is Identified in Two Siblings with Nude Severe Combined Immunodeficiency

FIRTINA S., Cipe F., NG Y. Y., KIYKIM A., HATIRNAZ NG Ö., Sudutan T., et al.
JOURNAL OF CLINICAL IMMUNOLOGY , cilt.39, sa.2, ss.144-147, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.

ERBİLGİN Y., Eskazan A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., Firtina S., et al.
Leukemia & lymphoma , cilt.60, sa.1, ss.200-207, 2019 (SCI-Expanded)

46. Kronik Myeloid Lösemide BCR-ABL Füzyon Transkriptinin Eş Zamanlı PCR ile Kantitasyonu İçin Referans Plazmid Oluşturulması

NG Y. Y., Yılmaz Z. H., HATIRNAZ NG Ö., SAYİTOĞLU M.
EXPERIMED , cilt.7, sa.13, ss.93-100, 2017 (Hakemli Dergi)

47. A novel pathogenic frameshift variant of CD3E gene in two T-B plus NK plus SCID patients from Turkey

Firtina S., Ng Y. Y., Ng Ö., Nepesov S., Yesilbas O., Kilercik M., et al.
IMMUNOGENETICS , cilt.69, sa.10, ss.653-659, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Hematolojik Maligniteler Moleküler Genetik Etiyoloji ve 2016 Dünya Sağlık Örgütü Sınıflaması

HATIRNAZ NG Ö., ÖZBEK U.
Türkiye Klinikleri Dergisi Tıbbi Genetik Özel Sayısı , cilt.2, sa.2, ss.88-98, 2017 (Hakemli Dergi)

49. Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia

Firtina S., Hatirnaz Ng Ö., Erbilgin Y., Ozbek U., Sayitoglu M.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.47, sa.1, ss.357-363, 2017 (SCI-Expanded, Scopus, TRDizin)

50. First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Işil Barlan in Turkey

Ng Y. Y., Şişko S., Hatırnaz Ng Ö., Çatal Tatonyan S., Sever Kaya D., Fırtına S., et al.
Turkish Journal of Immunology , cilt.3, sa.2, ss.47, 2015 (Scopus, TRDizin)

51. First Steps of the Genetic Monitorization in Primary Immune Deficiencies in the Lead of Prof. Dr. Isil Barlan in Turkey

Ng Y. Y., Sisko S., HATIRNAZ NG Ö., Tatonyan S. C., ŞATANA D., FIRTINA S., et al.
TURKISH JOURNAL OF IMMUNOLOGY , sa.2, ss.47, 2015 (ESCI, Scopus)

52. 8q24 bölgesi çocukluk çağı lenfoblastik lösemiler için potansiyel risk oluşturur mu

HATIRNAZ NG Ö., Can İ., SİNEM F., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
Deneysel Tıp Dergisi , cilt.5, sa.9, 2015 (Hakemli Dergi)

53. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia

HATIRNAZ NG Ö., Firtina S., Can I., KARAKAŞ Z., Agaoglu L., DOĞRU Ö., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.127-135, 2015 (SCI-Expanded, Scopus, TRDizin)

54. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

HATIRNAZ NG Ö., ERBİLGİN Y., Firtina S., Celkan T., KARAKAŞ Z., Aydogan G., et al.
BLOOD CANCER JOURNAL , cilt.4, 2014 (SCI-Expanded, Scopus)

55. LOCAL RENIN-ANGIOTENSIN SYSTEM IN NORMAL HEMATOPOIETIC AND MULTIPLE MYELOMA-RELATED PROGENITOR CELLS

Haznedaroglu I., Uz B., Ozcebe O., Buyukasik Y., Goker H., Aksu S., et al.
HAEMATOLOGICA , cilt.98, ss.768, 2013 (SCI-Expanded, Scopus)

56. Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

Maiorov E. G., Keskin O., Ng Ö., Ozbek U., Gursoy A.
BIOMED RESEARCH INTERNATIONAL , 2013 (SCI-Expanded, Scopus)

57. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL)

SAYİTOĞLU M., ERBİLGİN Y., HATIRNAZ NG Ö., Yildiz I., Celkan T., Anak S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.4, ss.325-333, 2012 (SCI-Expanded, Scopus, TRDizin)

58. AKUT LÖSEMİ HÜCRE SERİLERİNDE BETA KATENİN siRNA UYGULAMALARI

HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.
DENEYSEL TIP DERGİSİ , cilt.2, sa.3, ss.16-22, 2012 (Hakemli Dergi)

59. Genetic alterations in members of the Wnt pathway in acute leukemia

Erbilgin Y., Ng Ö., Mavi N., Ozbek U., Sayitoglu M.
Leukemia and Lymphoma , cilt.53, sa.3, ss.508-510, 2012 (SCI-Expanded, Scopus)

60. BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ

ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.
DENEYSEL TIP DERGİSİ , cilt.1, sa.2, ss.24-27, 2011 (Hakemli Dergi)

61. Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Koroglu G., Ozbeik U., Cefle K., et al.
Turkish Journal of Gastroenterology , cilt.18, sa.1, ss.53-57, 2007 (SCI-Expanded, Scopus, TRDizin)

62. HFE gene mutation, chronic liver disease, and iron overload in Turkey

Yoenal O., Hatirnaz Ö., Akyuez F., Oezbek U., Demir K., Kaymakoglu S., et al.
Digestive Diseases and Sciences , cilt.52, sa.11, ss.3298-3302, 2007 (SCI-Expanded, Scopus)

63. The SOCS-1 gene methylation in chronic myeloid leukemia patients

Hatirnaz M., Ure U., Ar C., Akyerli C., Soysal T., Ferhanoglu B., et al.
American Journal of Hematology , cilt.82, sa.8, ss.729-730, 2007 (SCI-Expanded, Scopus)

64. Sayımsal Gerçek Zamanlı Polimer Zincir Reaksiyonu ve Hematolojik Gen Anlatım Analizleri

SAVLI H., HATIRNAZ Ö.
TÜRKİYE KLİNİKLERİ TIP BİLİMLERİ DERGİSİ , cilt.24, sa.6, ss.653-660, 2004 (Hakemli Dergi)